Leaders of the House and Senate were at odds on Friday over the reasons for not reaching agreement about funding the federal government for the next six months to avert a federal shutdown by midnight as spending cuts and federal funding for the women's health organization emerged as key sticking points.
Shares of Immunogen Inc. (NASDAQ: IMGN) touched a new 52-week high and a 9-year high of $12.03 on Thursday. Roche Holding AG said an experimental drug T-DM1 was effective in a mid-stage study of breast cancer patients whose disease has spread.
Reports have surfaced that Matt Lauer, host of the Today show will step down from his position at the NBC morning show.
British pharmaceutical giant AstraZeneca Plc said the U.S. Food and Drug Administration (FDA) cleared its orphan drug vandetanib to treat advanced cases of a thyroid cancer.
Rumors are circulating the Internet Wednesday morning that Meredith Vieira will be leaving NBC and the “Today” show.
A European Space Agency satellite has measured record low levels of ozone over the Arctic, creating a situation similar to the ozone hole over the Antarctic.
Moussa Koussa, the former foreign minister of Libya who recently defected to the United Kingdom, may soon be answering questions about the tragic Lockerbie bombing of December 1988, according to Scottish prosecutors.
The U.S. Court of Appeals for the Federal Circuit heard arguments today that could decide the future of the biotech industry, in a case over whether genes can be patented.
The top pre-market NASDAQ Stock Market gainers are: McCormick & Schmick's Seafood Restaurants, VIVUS, Orexigen Therapeutics, Star Scientific, and Optimer Pharmaceuticals. The top pre-market NASDAQ Stock Market losers are: OmniVision Technologies, DepoMed, TD AMERITRADE Holding, Logitech International, and Check Point Software Technologies.
The top pre-market NASDAQ Stock Market gainers are: Synthesis Energy Systems, Tesla Motors, Randgold Resources, Dendreon, and Clean Energy Fuels. The top pre-market NASDAQ Stock Market losers are: Sinovac Biotech, OpenTable, Apollo Group, SciQuest, and NXP Semiconductors.
University of North Florida's student newspaper the Spinnaker has run into trouble after printing a picture of simulated oral sex on its front cover.
After the Internet backlash over the last few days, Food Network's Barefoot Contessa host, Ina Garten finally agreed to meet with a 6-year-old leukemia victim.
Hosni Mubarak, Egypt's deposed president, has been placed under house arrest along with his family, according to a statement from Egypt's Supreme Council of the Armed Forces.
Japan's Nuclear and Industrial Safety Agency said it detected several kinds of radioactive material in the water on the floor of reactor buildings at the Fukushima Daiichi nuclear power plant.
Egypt's first parliamentary election since the fall of president Hosni Mubarak will be conducted in September, a member of the Supreme Council of the Armed Forces (SCAF) confirmed on Monday.
While the metropolitan government of Tokyo has lifted its warning on radioactive tap water, the nearby prefectures of Chiba and Saitama reported radioactive iodine was detected in their tap water sources.
Radiation from the damaged Japan nuclear plant reaches U.S.. EPA, which is monitoring the radioactive substances and isotopes, assures that it is far below levels of concerns.
Oral arguments for the Myriad Genetics, Inc. appeals case is set to begin April 4 with a possible written decision in June 2011, RBC Capital Markets said.
US stocks edge down as turmoil in the Middle East continues to rage on.
The top pre-market NASDAQ stock market gainers are: Motricity, DryShips, Netflix, Curis, and Zions Bancorp. The top pre-market NASDAQ stock market losers are: IncrediMail, American Capital Agency, Skyworks Solutions, Hancock Holding, and Micron Technology.
The top pre-market NASDAQ stock market gainers are: Curis, TGC Industries, Verigy, Leap Wireless International, and Magic Software Enterprises. The top pre-market NASDAQ stock market losers are: Xenoport, Dish Network, DIRECTV, and Universal Display.
Quest Diagnostics Inc. announced an agreement to acquire smaller rival Celera Corp., a maker of diagnostic tests, for $8 per share to gain immediate access to genetic tests and pipeline of biomarkers.